Retour
Prix Immuron Limited (IMRN)
Graphique du cours de l'action IMRN
IMRN Gagner
Immuron Limited
$0.72
-3.67%
$-0.02
À la fermeture : Feb 11, 16:00:00 GMT-5
$0.72
-0.35%
$0
Post-Marché: Feb 11, 17:14:01 GMT-5
Earnings FAQ
Comment le bénéfice par action récent de IMRN se compare-t-il aux attentes ?
Comment les revenus de Immuron Limited IMRN se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Immuron Limited ?
Quel est le score de qualité des bénéfices pour Immuron Limited ?
Quand Immuron Limited publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Immuron Limited ?
Immuron Limited a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0.7537
Prix d'ouverture
$0.74
Plage de la journée
$0.7234 - $0.812
Plage de 52 semaines
$0.677 - $2.39
Volume
30.5K
Volume moyen
463.4K
BPA (TTM)
-0.63
Rendement en dividend
--
Capitalisation boursière
$5.8M
Qu’est-ce que Immuron Limited ?
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.
Fonctionnalités
Ressources
© 2025 Finture Development Limited. All rights reserved